Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications

뉴스 본문을 불러오고 있어요.

Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications | 웨이프 WAPE

Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications

기사 요약

관련 종목

댓글 —